Shahla Hosseini
Physical Medicine & Rehabilitation · West Chester, OHNPI 1275794984
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,698 of the $14,083 with a category attached, or 97.3%. E.r. Squibb & Sons, L.L.C. accounts for 74.9% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $10,653, more than ten times the $51 reported in 2019. Among physical medicine & rehabilitation clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 23 payments — averaging $612.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$11K
- Greenwich Biosciences, Inc.$3K
- Sanofi$94
- Bristol Myers Squibb$51
- Acorda Therapeutics, Inc$48
- Medtronic$24
- plus $166 from 9 others
Across 4 payments — averaging $17,841 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$52K
- E.r. Squibb & Sons, L.L.C.$20K
What the payments were for
- Consulting fees$13,69897%
- Speaking & faculty fees$480%
- Food & beverage$3372%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 6 | $10,541 |
| Greenwich Biosciences, Inc. | 1 | $3,159 |
| Sanofi | 1 | $94 |
| Bristol Myers Squibb | 2 | $51 |
| Acorda Therapeutics, Inc | 3 | $48 |
| Medtronic | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Mallinckrodt Enterprises LLC | 1 | $21 |
| Merz Pharmaceuticals, LLC | 1 | $21 |
| UCB, Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| AbbVie | 1 | $18 |
| Biogen | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
How this compares
$14,083 in reported general payments places this provider in the 95th percentile of 332 physical medicine & rehabilitation providers in Ohio.
See all physical medicine & rehabilitation providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 292 | $10,861 |
| Pregabalin | 46 | $1,727 |
| Tizanidine Hcl | 77 | $1,460 |
| Dantrolene Sodium | 12 | $1,349 |
| Modafinil | 11 | $817 |
| Gabapentin | 45 | $492 |
| Methocarbamol | 38 | $292 |
| Nortriptyline Hcl | 14 | $156 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in West Chester
- Michael BariaLewis Center$175K
- Kathryn MosherAkron$121K
- Marc OrlandoCincinnati$114K
- Aileen PadillaPerrysburg$73K
- Jeffrey StrakowskiColumbus$59K
- Kurt KuhlmanLima$46K
- Francois BethouxCleveland$39K
- Caitlin StuberColumbus$33K
- Francesco SammartinoDublin$32K
- Nikhil VermaColumbus$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.